| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.21 | 0.07 |